Request for Covid-19 Impact Assessment of this Report
The United States Amebiasis market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Amebiasis market, reaching US$ million by the year 2028. As for the Europe Amebiasis landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Amebiasis players cover Dr. Reddy’s Laboratories, Mission Pharmacal, Aceto Corporation, and Mylan Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Amebiasis market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Metronidazole
Paromomycin
Tinidazole
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Pharmacy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Dr. Reddy’s Laboratories
Mission Pharmacal
Aceto Corporation
Mylan Pharmaceuticals
Impax Laboratories
Pfizer
Sanofi
Lupin Pharmaceuticals
Glenmark Pharmaceuticals
Sun Pharmaceutical
Heritage Pharmaceuticals
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Amebiasis Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Amebiasis by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Amebiasis by Country/Region, 2017, 2022 & 2028
2.2 Amebiasis Segment by Type
2.2.1 Metronidazole
2.2.2 Paromomycin
2.2.3 Tinidazole
2.2.4 Other
2.3 Amebiasis Sales by Type
2.3.1 Global Amebiasis Sales Market Share by Type (2017-2022)
2.3.2 Global Amebiasis Revenue and Market Share by Type (2017-2022)
2.3.3 Global Amebiasis Sale Price by Type (2017-2022)
2.4 Amebiasis Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.5 Amebiasis Sales by Application
2.5.1 Global Amebiasis Sale Market Share by Application (2017-2022)
2.5.2 Global Amebiasis Revenue and Market Share by Application (2017-2022)
2.5.3 Global Amebiasis Sale Price by Application (2017-2022)
3 Global Amebiasis by Company
3.1 Global Amebiasis Breakdown Data by Company
3.1.1 Global Amebiasis Annual Sales by Company (2020-2022)
3.1.2 Global Amebiasis Sales Market Share by Company (2020-2022)
3.2 Global Amebiasis Annual Revenue by Company (2020-2022)
3.2.1 Global Amebiasis Revenue by Company (2020-2022)
3.2.2 Global Amebiasis Revenue Market Share by Company (2020-2022)
3.3 Global Amebiasis Sale Price by Company
3.4 Key Manufacturers Amebiasis Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Amebiasis Product Location Distribution
3.4.2 Players Amebiasis Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Amebiasis by Geographic Region
4.1 World Historic Amebiasis Market Size by Geographic Region (2017-2022)
4.1.1 Global Amebiasis Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Amebiasis Annual Revenue by Geographic Region
4.2 World Historic Amebiasis Market Size by Country/Region (2017-2022)
4.2.1 Global Amebiasis Annual Sales by Country/Region (2017-2022)
4.2.2 Global Amebiasis Annual Revenue by Country/Region
4.3 Americas Amebiasis Sales Growth
4.4 APAC Amebiasis Sales Growth
4.5 Europe Amebiasis Sales Growth
4.6 Middle East & Africa Amebiasis Sales Growth
5 Americas
5.1 Americas Amebiasis Sales by Country
5.1.1 Americas Amebiasis Sales by Country (2017-2022)
5.1.2 Americas Amebiasis Revenue by Country (2017-2022)
5.2 Americas Amebiasis Sales by Type
5.3 Americas Amebiasis Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Amebiasis Sales by Region
6.1.1 APAC Amebiasis Sales by Region (2017-2022)
6.1.2 APAC Amebiasis Revenue by Region (2017-2022)
6.2 APAC Amebiasis Sales by Type
6.3 APAC Amebiasis Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Amebiasis by Country
7.1.1 Europe Amebiasis Sales by Country (2017-2022)
7.1.2 Europe Amebiasis Revenue by Country (2017-2022)
7.2 Europe Amebiasis Sales by Type
7.3 Europe Amebiasis Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Amebiasis by Country
8.1.1 Middle East & Africa Amebiasis Sales by Country (2017-2022)
8.1.2 Middle East & Africa Amebiasis Revenue by Country (2017-2022)
8.2 Middle East & Africa Amebiasis Sales by Type
8.3 Middle East & Africa Amebiasis Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Amebiasis
10.3 Manufacturing Process Analysis of Amebiasis
10.4 Industry Chain Structure of Amebiasis
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Amebiasis Distributors
11.3 Amebiasis Customer
12 World Forecast Review for Amebiasis by Geographic Region
12.1 Global Amebiasis Market Size Forecast by Region
12.1.1 Global Amebiasis Forecast by Region (2023-2028)
12.1.2 Global Amebiasis Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Amebiasis Forecast by Type
12.7 Global Amebiasis Forecast by Application
13 Key Players Analysis
13.1 Dr. Reddy’s Laboratories
13.1.1 Dr. Reddy’s Laboratories Company Information
13.1.2 Dr. Reddy’s Laboratories Amebiasis Product Offered
13.1.3 Dr. Reddy’s Laboratories Amebiasis Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Dr. Reddy’s Laboratories Main Business Overview
13.1.5 Dr. Reddy’s Laboratories Latest Developments
13.2 Mission Pharmacal
13.2.1 Mission Pharmacal Company Information
13.2.2 Mission Pharmacal Amebiasis Product Offered
13.2.3 Mission Pharmacal Amebiasis Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Mission Pharmacal Main Business Overview
13.2.5 Mission Pharmacal Latest Developments
13.3 Aceto Corporation
13.3.1 Aceto Corporation Company Information
13.3.2 Aceto Corporation Amebiasis Product Offered
13.3.3 Aceto Corporation Amebiasis Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Aceto Corporation Main Business Overview
13.3.5 Aceto Corporation Latest Developments
13.4 Mylan Pharmaceuticals
13.4.1 Mylan Pharmaceuticals Company Information
13.4.2 Mylan Pharmaceuticals Amebiasis Product Offered
13.4.3 Mylan Pharmaceuticals Amebiasis Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Mylan Pharmaceuticals Main Business Overview
13.4.5 Mylan Pharmaceuticals Latest Developments
13.5 Impax Laboratories
13.5.1 Impax Laboratories Company Information
13.5.2 Impax Laboratories Amebiasis Product Offered
13.5.3 Impax Laboratories Amebiasis Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Impax Laboratories Main Business Overview
13.5.5 Impax Laboratories Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Amebiasis Product Offered
13.6.3 Pfizer Amebiasis Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Sanofi
13.7.1 Sanofi Company Information
13.7.2 Sanofi Amebiasis Product Offered
13.7.3 Sanofi Amebiasis Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Sanofi Main Business Overview
13.7.5 Sanofi Latest Developments
13.8 Lupin Pharmaceuticals
13.8.1 Lupin Pharmaceuticals Company Information
13.8.2 Lupin Pharmaceuticals Amebiasis Product Offered
13.8.3 Lupin Pharmaceuticals Amebiasis Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Lupin Pharmaceuticals Main Business Overview
13.8.5 Lupin Pharmaceuticals Latest Developments
13.9 Glenmark Pharmaceuticals
13.9.1 Glenmark Pharmaceuticals Company Information
13.9.2 Glenmark Pharmaceuticals Amebiasis Product Offered
13.9.3 Glenmark Pharmaceuticals Amebiasis Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Glenmark Pharmaceuticals Main Business Overview
13.9.5 Glenmark Pharmaceuticals Latest Developments
13.10 Sun Pharmaceutical
13.10.1 Sun Pharmaceutical Company Information
13.10.2 Sun Pharmaceutical Amebiasis Product Offered
13.10.3 Sun Pharmaceutical Amebiasis Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Sun Pharmaceutical Main Business Overview
13.10.5 Sun Pharmaceutical Latest Developments
13.11 Heritage Pharmaceuticals
13.11.1 Heritage Pharmaceuticals Company Information
13.11.2 Heritage Pharmaceuticals Amebiasis Product Offered
13.11.3 Heritage Pharmaceuticals Amebiasis Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Heritage Pharmaceuticals Main Business Overview
13.11.5 Heritage Pharmaceuticals Latest Developments
14 Research Findings and Conclusion
Table 1. Amebiasis Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Amebiasis Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Metronidazole
Table 4. Major Players of Paromomycin
Table 5. Major Players of Tinidazole
Table 6. Major Players of Other
Table 7. Global Amebiasis Sales by Type (2017-2022) & (K MT)
Table 8. Global Amebiasis Sales Market Share by Type (2017-2022)
Table 9. Global Amebiasis Revenue by Type (2017-2022) & ($ million)
Table 10. Global Amebiasis Revenue Market Share by Type (2017-2022)
Table 11. Global Amebiasis Sale Price by Type (2017-2022) & (USD/MT)
Table 12. Global Amebiasis Sales by Application (2017-2022) & (K MT)
Table 13. Global Amebiasis Sales Market Share by Application (2017-2022)
Table 14. Global Amebiasis Revenue by Application (2017-2022)
Table 15. Global Amebiasis Revenue Market Share by Application (2017-2022)
Table 16. Global Amebiasis Sale Price by Application (2017-2022) & (USD/MT)
Table 17. Global Amebiasis Sales by Company (2020-2022) & (K MT)
Table 18. Global Amebiasis Sales Market Share by Company (2020-2022)
Table 19. Global Amebiasis Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Amebiasis Revenue Market Share by Company (2020-2022)
Table 21. Global Amebiasis Sale Price by Company (2020-2022) & (USD/MT)
Table 22. Key Manufacturers Amebiasis Producing Area Distribution and Sales Area
Table 23. Players Amebiasis Products Offered
Table 24. Amebiasis Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Amebiasis Sales by Geographic Region (2017-2022) & (K MT)
Table 28. Global Amebiasis Sales Market Share Geographic Region (2017-2022)
Table 29. Global Amebiasis Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Amebiasis Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Amebiasis Sales by Country/Region (2017-2022) & (K MT)
Table 32. Global Amebiasis Sales Market Share by Country/Region (2017-2022)
Table 33. Global Amebiasis Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Amebiasis Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Amebiasis Sales by Country (2017-2022) & (K MT)
Table 36. Americas Amebiasis Sales Market Share by Country (2017-2022)
Table 37. Americas Amebiasis Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Amebiasis Revenue Market Share by Country (2017-2022)
Table 39. Americas Amebiasis Sales by Type (2017-2022) & (K MT)
Table 40. Americas Amebiasis Sales Market Share by Type (2017-2022)
Table 41. Americas Amebiasis Sales by Application (2017-2022) & (K MT)
Table 42. Americas Amebiasis Sales Market Share by Application (2017-2022)
Table 43. APAC Amebiasis Sales by Region (2017-2022) & (K MT)
Table 44. APAC Amebiasis Sales Market Share by Region (2017-2022)
Table 45. APAC Amebiasis Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Amebiasis Revenue Market Share by Region (2017-2022)
Table 47. APAC Amebiasis Sales by Type (2017-2022) & (K MT)
Table 48. APAC Amebiasis Sales Market Share by Type (2017-2022)
Table 49. APAC Amebiasis Sales by Application (2017-2022) & (K MT)
Table 50. APAC Amebiasis Sales Market Share by Application (2017-2022)
Table 51. Europe Amebiasis Sales by Country (2017-2022) & (K MT)
Table 52. Europe Amebiasis Sales Market Share by Country (2017-2022)
Table 53. Europe Amebiasis Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Amebiasis Revenue Market Share by Country (2017-2022)
Table 55. Europe Amebiasis Sales by Type (2017-2022) & (K MT)
Table 56. Europe Amebiasis Sales Market Share by Type (2017-2022)
Table 57. Europe Amebiasis Sales by Application (2017-2022) & (K MT)
Table 58. Europe Amebiasis Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Amebiasis Sales by Country (2017-2022) & (K MT)
Table 60. Middle East & Africa Amebiasis Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Amebiasis Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Amebiasis Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Amebiasis Sales by Type (2017-2022) & (K MT)
Table 64. Middle East & Africa Amebiasis Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Amebiasis Sales by Application (2017-2022) & (K MT)
Table 66. Middle East & Africa Amebiasis Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Amebiasis
Table 68. Key Market Challenges & Risks of Amebiasis
Table 69. Key Industry Trends of Amebiasis
Table 70. Amebiasis Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Amebiasis Distributors List
Table 73. Amebiasis Customer List
Table 74. Global Amebiasis Sales Forecast by Region (2023-2028) & (K MT)
Table 75. Global Amebiasis Sales Market Forecast by Region
Table 76. Global Amebiasis Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Amebiasis Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Amebiasis Sales Forecast by Country (2023-2028) & (K MT)
Table 79. Americas Amebiasis Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Amebiasis Sales Forecast by Region (2023-2028) & (K MT)
Table 81. APAC Amebiasis Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Amebiasis Sales Forecast by Country (2023-2028) & (K MT)
Table 83. Europe Amebiasis Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Amebiasis Sales Forecast by Country (2023-2028) & (K MT)
Table 85. Middle East & Africa Amebiasis Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Amebiasis Sales Forecast by Type (2023-2028) & (K MT)
Table 87. Global Amebiasis Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Amebiasis Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Amebiasis Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Amebiasis Sales Forecast by Application (2023-2028) & (K MT)
Table 91. Global Amebiasis Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Amebiasis Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Amebiasis Revenue Market Share Forecast by Application (2023-2028)
Table 94. Dr. Reddy’s Laboratories Basic Information, Amebiasis Manufacturing Base, Sales Area and Its Competitors
Table 95. Dr. Reddy’s Laboratories Amebiasis Product Offered
Table 96. Dr. Reddy’s Laboratories Amebiasis Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 97. Dr. Reddy’s Laboratories Main Business
Table 98. Dr. Reddy’s Laboratories Latest Developments
Table 99. Mission Pharmacal Basic Information, Amebiasis Manufacturing Base, Sales Area and Its Competitors
Table 100. Mission Pharmacal Amebiasis Product Offered
Table 101. Mission Pharmacal Amebiasis Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 102. Mission Pharmacal Main Business
Table 103. Mission Pharmacal Latest Developments
Table 104. Aceto Corporation Basic Information, Amebiasis Manufacturing Base, Sales Area and Its Competitors
Table 105. Aceto Corporation Amebiasis Product Offered
Table 106. Aceto Corporation Amebiasis Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 107. Aceto Corporation Main Business
Table 108. Aceto Corporation Latest Developments
Table 109. Mylan Pharmaceuticals Basic Information, Amebiasis Manufacturing Base, Sales Area and Its Competitors
Table 110. Mylan Pharmaceuticals Amebiasis Product Offered
Table 111. Mylan Pharmaceuticals Amebiasis Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 112. Mylan Pharmaceuticals Main Business
Table 113. Mylan Pharmaceuticals Latest Developments
Table 114. Impax Laboratories Basic Information, Amebiasis Manufacturing Base, Sales Area and Its Competitors
Table 115. Impax Laboratories Amebiasis Product Offered
Table 116. Impax Laboratories Amebiasis Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 117. Impax Laboratories Main Business
Table 118. Impax Laboratories Latest Developments
Table 119. Pfizer Basic Information, Amebiasis Manufacturing Base, Sales Area and Its Competitors
Table 120. Pfizer Amebiasis Product Offered
Table 121. Pfizer Amebiasis Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 122. Pfizer Main Business
Table 123. Pfizer Latest Developments
Table 124. Sanofi Basic Information, Amebiasis Manufacturing Base, Sales Area and Its Competitors
Table 125. Sanofi Amebiasis Product Offered
Table 126. Sanofi Amebiasis Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 127. Sanofi Main Business
Table 128. Sanofi Latest Developments
Table 129. Lupin Pharmaceuticals Basic Information, Amebiasis Manufacturing Base, Sales Area and Its Competitors
Table 130. Lupin Pharmaceuticals Amebiasis Product Offered
Table 131. Lupin Pharmaceuticals Amebiasis Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 132. Lupin Pharmaceuticals Main Business
Table 133. Lupin Pharmaceuticals Latest Developments
Table 134. Glenmark Pharmaceuticals Basic Information, Amebiasis Manufacturing Base, Sales Area and Its Competitors
Table 135. Glenmark Pharmaceuticals Amebiasis Product Offered
Table 136. Glenmark Pharmaceuticals Amebiasis Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 137. Glenmark Pharmaceuticals Main Business
Table 138. Glenmark Pharmaceuticals Latest Developments
Table 139. Sun Pharmaceutical Basic Information, Amebiasis Manufacturing Base, Sales Area and Its Competitors
Table 140. Sun Pharmaceutical Amebiasis Product Offered
Table 141. Sun Pharmaceutical Amebiasis Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 142. Sun Pharmaceutical Main Business
Table 143. Sun Pharmaceutical Latest Developments
Table 144. Heritage Pharmaceuticals Basic Information, Amebiasis Manufacturing Base, Sales Area and Its Competitors
Table 145. Heritage Pharmaceuticals Amebiasis Product Offered
Table 146. Heritage Pharmaceuticals Amebiasis Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 147. Heritage Pharmaceuticals Main Business
Table 148. Heritage Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Amebiasis
Figure 2. Amebiasis Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Amebiasis Sales Growth Rate 2017-2028 (K MT)
Figure 7. Global Amebiasis Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Amebiasis Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Metronidazole
Figure 10. Product Picture of Paromomycin
Figure 11. Product Picture of Tinidazole
Figure 12. Product Picture of Other
Figure 13. Global Amebiasis Sales Market Share by Type in 2021
Figure 14. Global Amebiasis Revenue Market Share by Type (2017-2022)
Figure 15. Amebiasis Consumed in Hospital
Figure 16. Global Amebiasis Market: Hospital (2017-2022) & (K MT)
Figure 17. Amebiasis Consumed in Pharmacy
Figure 18. Global Amebiasis Market: Pharmacy (2017-2022) & (K MT)
Figure 19. Global Amebiasis Sales Market Share by Application (2017-2022)
Figure 20. Global Amebiasis Revenue Market Share by Application in 2021
Figure 21. Amebiasis Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Amebiasis Revenue Market Share by Company in 2021
Figure 23. Global Amebiasis Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Amebiasis Revenue Market Share by Geographic Region in 2021
Figure 25. Global Amebiasis Sales Market Share by Region (2017-2022)
Figure 26. Global Amebiasis Revenue Market Share by Country/Region in 2021
Figure 27. Americas Amebiasis Sales 2017-2022 (K MT)
Figure 28. Americas Amebiasis Revenue 2017-2022 ($ Millions)
Figure 29. APAC Amebiasis Sales 2017-2022 (K MT)
Figure 30. APAC Amebiasis Revenue 2017-2022 ($ Millions)
Figure 31. Europe Amebiasis Sales 2017-2022 (K MT)
Figure 32. Europe Amebiasis Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Amebiasis Sales 2017-2022 (K MT)
Figure 34. Middle East & Africa Amebiasis Revenue 2017-2022 ($ Millions)
Figure 35. Americas Amebiasis Sales Market Share by Country in 2021
Figure 36. Americas Amebiasis Revenue Market Share by Country in 2021
Figure 37. United States Amebiasis Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Amebiasis Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Amebiasis Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Amebiasis Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Amebiasis Sales Market Share by Region in 2021
Figure 42. APAC Amebiasis Revenue Market Share by Regions in 2021
Figure 43. China Amebiasis Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Amebiasis Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Amebiasis Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Amebiasis Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Amebiasis Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Amebiasis Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Amebiasis Sales Market Share by Country in 2021
Figure 50. Europe Amebiasis Revenue Market Share by Country in 2021
Figure 51. Germany Amebiasis Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Amebiasis Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Amebiasis Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Amebiasis Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Amebiasis Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Amebiasis Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Amebiasis Revenue Market Share by Country in 2021
Figure 58. Egypt Amebiasis Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Amebiasis Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Amebiasis Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Amebiasis Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Amebiasis Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Amebiasis in 2021
Figure 64. Manufacturing Process Analysis of Amebiasis
Figure 65. Industry Chain Structure of Amebiasis
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...